Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa pennsylvania
  4. epitopes
Show results for
Products
Services

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Pennsylvania

Epitopes Equipment Supplied In Usa Pennsylvania

4 equipment items found
In PennsylvaniaAvailable In PennsylvaniaNear Pennsylvania

Model MuSK-CAART - Potential Treatment Under Development for Patients with Myasthenia Gravis (MG)

Model MuSK-CAART - Potential Treatment Under Development for Patients with Myasthenia Gravis (MG)

Manufactured by:Cabaletta Bio, Inc.   based inPhiladelphia, PENNSYLVANIA (USA)
Precision Approach to Address the Underlying Cause of Disease: Our second candidate, MuSK-CAART, is designed to treat myasthenia gravis (MG), an autoimmune disease affecting the neuromuscular junction that can lead to motor impairment, muscle weakness, and respiratory ...
CONTACT SUPPLIER

Model DSG3-CAART - Potential Treatment Under Development for Patients with Mucosal Pemphigus Vulgaris (mPV)

Model DSG3-CAART - Potential Treatment Under Development for Patients with Mucosal Pemphigus Vulgaris (mPV)

Manufactured by:Cabaletta Bio, Inc.   based inPhiladelphia, PENNSYLVANIA (USA)
Our lead product candidate, DSG3-CAART, is being developed to treat mucosal pemphigus vulgaris (mPV), a blistering skin disease that affects mucous membranes. mPV is caused by autoantibodies that attack the cell adhesion protein desmoglein 3, or DSG3. DSG3-CAART is designed to selectively target and kill the B cells that produce DSG3 antibodies while preserving the healthy B cells critical to ...
CONTACT SUPPLIER

Model FVIII-CAART - Discovery-Stage Candidate for Hemophilia

Model FVIII-CAART - Discovery-Stage Candidate for Hemophilia

Manufactured by:Cabaletta Bio, Inc.   based inPhiladelphia, PENNSYLVANIA (USA)
In addition to our work on autoimmune disease treatments, we are investigating the viability of CAART as an adjunct in cases where the immune system produces antibodies against current therapies (rather than against the patient’s cells). We believe our approach has the potential to destroy those antibodies by ablating B cells, similar to the method we have used to combat autoimmune disease. ...
CONTACT SUPPLIER

Model PLA2R-CAART - Potential Treatment Under Development for Patients with PLA2R-Associated Membranous Nephropathy (MN)

Model PLA2R-CAART - Potential Treatment Under Development for Patients with PLA2R-Associated Membranous Nephropathy (MN)

Manufactured by:Cabaletta Bio, Inc.   based inPhiladelphia, PENNSYLVANIA (USA)
PLA2R-CAART is being developed to treat patients with PLA2R-associated membranous nephropathy (MN), a B cell-mediated autoimmune disease that affects the kidneys. B cells produce autoantibodies, which are believed to form immune complexes that are deposited at the glomerular basement membrane, causing damage of the filtration barrier, and leading to proteinuria. Over time, ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT